Ranbaxy beats class certification bid in case over contamination threat

New Delhi: A federal judge has refused to certify a class of consumers who sued India’s Ranbaxy Laboratories Ltd to obtain a refund for generic Lipitor pills they bought that the company later recalled due to a possible contamination threat.

U.S. District Judge Peter Sheridan in Trenton, New Jersey in a ruling made public on Wednesday said the case was not appropriate for class treatment because the laws of 50 different states would apply, meaning common issues did not predominate.

Read Also: Ranbaxy Fiasco: Malvinder Singh told to pay 3.5 million Singapore dollars